Main > ONCOLOGY (**) > Skin Cancer>Melanoma>UnResectable > TREAT.: > USA. I. Tumor derived Autologous>



USA. I. Tumor derived Autologous>'s subsections
(*) USA Approval Date: 2024. 02.16
> T Cell Immunotherapy Suspension>
Company
Generic Name
or Metastatic
PR Web-Site
TM
USA Patent Numbers

USA. I. Tumor derived Autologous>'s products
This section has no products